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Open access under the Elsa b s t r a c t
This work reports results of re-infection of BALB/c and C57BL/6 mice with different recombinant strains
of Toxoplasma gondii. Mice were prime-infected with the non-virulent D8 strain and challenged with vir-
ulent strains. PCR–RFLP of cS10-A6 genetic marker of T. gondii demonstrated that BALB/c mice were re-
infected with the EGS strain, while C57BL/6 mice were re-infected with the EGS and CH3 strains. Levels
of IFN-c and IL-10 after D8 prime-infection were lower in C57BL/6 than in BALB/c mice. Brain inﬂamma-
tion after D8 prime-infection was more intense in C57BL/6 than in BALB/c mice. It was shown that re-
infection depends on mice lineage and genotype of the strain used in the challenge.
 2011 Elsevier Inc. Open access under the Elsevier OA license.1. Introduction
Primary infection with Toxoplasma gondii gives life-long immu-
nity, preventing re-infection (Filisetti and Candolﬁ, 2004). In the
early phase of toxoplasmosis, resistance in mice is related to
the initial production of IL-12 and INF-c by natural killer cells
(Buzoni-Gatel et al., 2006). In the chronic phase, TH1 CD4+ cells
and CD8+ cytolytic lymphocytes produce INF-c (Pfaff et al.,
2007) through activity against tachyzoites or cells infected with
T. gondii (Subauste et al., 1991), preventing re-infection. However,
cases of congenital toxoplasmosis in immunocompetent women
in the chronic phase have been reported, showing the possibility
of re-infection at least in pregnant women (Elbez-Rubinstein
et al., 2009). Resistance and susceptibility in mice experimentally
infected with T. gondii varies depending on the route of infection,
type of inoculum, parasite strain, and the host immune response
(Dao et al., 2001; Brandão et al., 2009).
The genes of major histocompatibility complex (MHC) exert
considerable inﬂuence on the outcome of experimental toxoplas-
mosis in mice (Blackwell et al., 1993; McLeod et al., 1996). The
class I MHC genes (H-2 haplotype) perform critical functions in
resistance to encephalitis and control of cerebral cyst loads (Brownitor).
evier OA license.et al., 1995). BALB/c mice display the allele d, which confers resis-
tance against encephalitis caused by T. gondii infection, while
C57BL/6 mice have the allele b, which is associated with suscepti-
bility (Suzuki et al., 1994). The genotype of T. gondii strain also
plays a role in determining resistance to encephalitis in mice
(Fux et al., 2003). However, little is known about the inﬂuence of
genetics on the host co-infection with different recombinant
strains of T. gondii, such as those commonly occurring in Brazil
(Ferreira et al., 2006; Dubey and Su, 2009).
This study reports results of re-infection of BALB/c and C57BL/6
mice after prime infection with a non-virulent recombinant strain
of T. gondii isolated in Brazil as well as of the inﬂuence of the host
on resistance to re-infection with T. gondii.2. Material and methods
2.1. T. gondii strains
Three different recombinant T. gondii strains isolated in Brazil
were used in this study. The differences in their recombinant geno-
types after analysis of eight genetic markers (Fux et al., 2003) were
described in details elsewhere (Ferreira et al., 2006). The D8 (non-
virulent) and CH3 (virulent) strains, both cystogenic, were isolated
from a dog and a chicken, respectively. The EGS strain (virulent,
cystogenic) was isolated from a human with congenital
toxoplasmosis.
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Female Swiss, BALB/c and C57BL/6 mice, 8 weeks of age, were
obtained from the animal breeding facility (Centro de Bioterismo
– CEBIO) of the Universidade Federal de Minas Gerais (UFMG).
Swiss mice were used for parasite maintenance and to obtain tach-
yzoites for DNA extraction. BALB/c and C57BL/6 mice were used for
re-infection experiments and bioassays. BALB/c and C57Bl/6 mice
were kept in the animal house facility of the Biological Sciences
Institute, Federal University of Minas Gerais, Brazil. Food and water
were available to the animals throughout the experiment. All
experimentation with animals was performed in accordance to
the guidelines of the Institutional Ethics Committee (CETEA-UFMG
protocol No. 038/05).2.3. Prime infection and re-infection of mice with T. gondii
The strains D8, EGS and CH3 were maintained in vivo as cysts in
Swiss mice carriers. Maintenance was performed by successive per
oral (p.o.) inoculation of cysts isolated from brains of previously in-
fected animals. In the case of EGS and CH3, the infected Swiss res-
ervoirs were treated with sulfadiazine for 10 days after infection to
obtain cysts. For infection experiments, BALB/c and C57BL/6 mice
were divided in groups of 7–10 animals (Table 1) and inoculated
with a p.o. dose of 20 cysts of the D8 strain. Forty-ﬁve days after
primary D8 infection (recent chronic toxoplasmosis), animals were
challenged with 20 cysts p.o. of either EGS or CH3 strains. As con-
trols, animals were inoculated with the D8 strain and kept without
challenge. Groups of animals inoculated with EGS or CH3 strains,
without the D8 primary infection, were also used as controls. A
detailed description of all groups is shown in Table 1. After chal-
lenge, mortality was followed over 30 days. The mice that survived
were sacriﬁced by cervical dislocation; the brains were removed
and homogenized in 1 ml of phosphate buffered saline, pH 7.2
and examined for DNA analyses by PCR–RFLP (Brandão et al.,
2009) and bioassay. For bioassay, only one normal BALB/c or
C57BL/6 mice was infected i.p. with 20 brain cysts from each
mouse that survived challenge. Bioassay was considered positive
when tachyzoites in the peritoneal ﬂuid or cysts in the brain were
found. Bioassay was used as an auxiliary criterion to PCR–RFLP,
demonstrating re-infection by mortality rate.Table 1
Survival, PCR and bioassay of BALB/c and C57BL/6 mice prime infected with D8 strain and
Groupa Strains Re-infection
BALB/c Survival n/Nb (%)
A D8 + EGS 7/7 (100)
B D8 + CH3 8/10 (80)*
C D8 10/10 (100)
D EGS 0/10 (0)
E CH3 0/10 (0)
C57BL/6
F D8 + EGS 6/7 (85.7)**
G D8 + CH3 6/7 (85.7)**
H D8 6/7 (85.7)**
I EGS 0/10 (0)
J CH3 0/10 (0)
a Groups A and B: BALB/c mice challenged with EGS or CH3 strains after primary D8 in
(BALB/c controls). Groups F and G: C57BL/6 mice challenged with EGS or CH3 strains afte
or CH3 strains (C57BL/6 controls). After challenge, mortality was observed during 30 da
b Number of survivors (n) of the total number of challenged mice (N).
c Number (n) of mice presenting the two strains (positive PCR–RFLP at cS10-A6 locus
d Number of survivors (n) of the total number of bio-assayed animals (N).
e Number of mice with brain cysts (n) of the total number of bio-assayed mice (N).
f ND – Not done.
g NS – No survival.
* Death occurred 17–19 days after challenge.
** Death occurred 9–12 days after challenge.2.4. Polymerase chain reaction – restriction fragment length
polymorphisms (PCR–RFLP)
The main criteria to conﬁrm re-infection with T. gondii was
PCR–RFLP. We performed genotyping of T. gondii samples from in-
fected animals using the cS10-A6 genetic marker (Su et al., 2002),
which was shown to distinguish D8 from EGS and CH3 strains
(Ferreira et al., 2006). First, we recovered brain cysts from each
BALB/c or C57BL/6 that survived challenge infection and inoculated
them by i.p. injection of 200–300 cysts in Swiss mice. After 5–
7 days of infection, Swiss mice were sacriﬁced and peritoneal
washes were performed under aseptic conditions to obtain tach-
yzoites. Then, DNA samples were extracted from tachyzoites with
phenol–chloroform and submitted to PCR–RFLP, as described else-
where (Ferreira et al., 2006; Sambrook et al., 1989). Ampliﬁcations
were performed with primers 50-CTGGTTACATTTTCGCCTATCA-30
and 30-CCTAGTCCAAACTAGGGCTTGA-50, producing a 341 bp frag-
ment. PCR products were digested with restriction enzyme RsaI.
The DNA banding pattern was resolved in 5% polyacrylamide gels
and silver stained. The RH88 (type I), ME49 (type II) and VEG (type
III) strains were used as references.
2.5. Splenocyte cultures and cytokine measurement
Spleens were removed from D8 infected and non-infected con-
trol animals at 45 days after primary infection and macerated to
obtain single cell suspensions. Red blood cells were lysed using a
buffer containing 0.16 M NH4Cl and 0.017 M Tris–HCl pH = 7.5.
Splenocyte suspensions were washed three times and adjusted to
107 cells/ml in RPMI-1640 supplemented with 10% fetal calf serum,
25 mM HEPES and 40 mg/l gentamicin. The cell suspension was
distributed (500 ll/well) in 24-well tissue culture plates and cul-
tured with 10 lg/ml STAg, 5 lg/ml, Con A or RPMI medium alone
for 72 h at 37 C in 5% CO2. The cytokines IL-10 and IFN-c were
quantiﬁed in supernatants of the spleen cells using the BD OptEIA
kits (BD Biosciences), according to the manufacturer instructions.
2.6. Histopathology
A quarter of the brain of the surviving mice was collected in 10%
formalin in PBS and subjected to histopathology evaluation.challenged after 45 days with EGS or CH3 strains of Toxoplasma gondii.
Bioassay of survivors
PCR–RFLP n/Nc (%) Survival n/Nd (%) Cysts n/Ne
5/7 (71) 6/7 (86) 6/6
0/8 (0) 8/8 (100) 8/8
NDf 10/10 (100) 10/10
NSg – –
NS – –
6/6 (100) 1/6 (16.7) 1/1
6/6 (100) 1/6 (16.7) 1/1
ND 3/6 (50) 3/3
NS – –
NS – –
fection. Groups C, D and E: BALB/c mice prime infected with D8, EGS or CH3 strains
r primary D8 infection. Groups H, I and J: C57BL/6 mice prime-infected with D8, EGS
ys. The experiment was repeated twice and provided similar results.
) of the total number of survivors after challenge (N).
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into 3–5 lm slices stained with hematoxylin–eosin and examined
under a light microscope. Morphometrical studies of glial nodules
and perivascular inﬂammatory inﬁltrates were performed by ana-
lyzing images of 20 randomly selected ﬁelds (total area
1.5  106 lm2) of tissue fragment sections on a single slide per ani-
mal. All analyses were performed using a 40 objective and images
were analyzed using Leica QWin software (Leica Microsystems).
2.7. Statistical analysis
The intensity of inﬂammation in the brain as well as cytokine
levels in the supernatants from the splenocyte cultures obtained
from the different mice groups were analyzed by the Student’s t
test. The differences were considered statistically signiﬁcant when
p < 0.05.
3. Results
3.1. Mortality
The results of challenge infections are shown in Table 1. We ob-
served that the primary infection of BALB/c mice with the D8 strain
prevented mortality caused by EGS strain (group A) and signiﬁ-
cantly reduced the mortality caused by CH3 strain (group B). The
cause of death of two BALB/c mice challenged with CH3 strain
was not determined. In the case of C57BL/6 mice, priming with
D8 strain lead to a signiﬁcant reduction of mortality caused the
EGS and CH3, from 100% to around 14% mortality (groups F and
G, respectively). Both BALB/c and C57BL/6 survivors had brain
cysts, independent of the strain of challenge. The cysts loads were
similar in all groups and comparable to number of brain cysts in
animals that received only D8 infection (data not shown).
3.2. Genotyping of T. gondii by PCR–RFLP
To evaluate if the challenge inoculation could induce re-infec-
tion and co-existence of two different strains of T. gondii in the
brain of the same animal, we performed analysis of the T. gondii
marker cS10-A6 in DNA samples obtained from parasites recovered
from infected animals. Table 1 shows that the EGS strain success-
fully re-infects animals that were previously inoculated with D8
strain, since 71% of specimens from BALB/c group A and 100% of
specimens from C57BL/6 group F showed positive PCR results for
both strains.
On the other hand, successful re-infection with CH3 strain
appears to depend on the strain of mice. BALB/c are resistant toFig. 1. Polymerase chain reaction-restriction fragment length polymorphism (PCR–
RFLP) of Toxoplasma gondii at cS10-A6 locus. Products were digested with restriction
endonuclease RsaI and revealed in 5% polyacrylamide gel to verify re-infection of
C57BL/6 mice challenged with the CH3 strain, 45 days after primary D8 strain
infection. RH88 (Type I), ME49 (Type II) and VEG (Type III) strains were used as
reference. D8 + CH3 = Six mice challenged with the CH3 after primary D8 infection.
M = molecular weight marker (Promega 100pb), C = negative control, without DNA.
The experiment was repeated twice and provided similar results.re-infection by CH3 since it was observed that none of the survi-
vors from group B, analyzed by PCR–RFLP, showed concomitant
presence of D8 and CH3 strains. C57BL/6 mice seem to be more
susceptible to re-infection than BALB/c, taking in account that all
specimens from group G showed co-existence of D8 and CH3
strains. Representative results of PCR–RFLP analysis of T. gondii
DNA from C57BL/6 mice challenged with CH3 strain are shown
in Fig. 1.
3.3. Bioassay
Bioassaywas conducted as an auxiliary criterion for re-infection.
Twenty cysts obtained from surviving BALB/c mice were used to in-
fect naïve BALB/c, and mortality in recipients groups was followed
for 30 days (Table 1). A similar bioassay was performed with
C57BL/6 mice: Twenty brain cysts of each surviving mouse were
used to infect one naïve C57BL/6mouse. Fourteen percentmortality
(one of seven animals) was observed in naïve BALB/c mice that re-
ceived cysts obtained from survivors of group A (primed with D8
and challenged with EGS). Bioassay performed with cyst samples
fromsurvivors of groupB (challengedwithCH3)didnot inducemor-
tality. Bioassay of T. gondii cysts obtained from C57BL/6 mice survi-
vors (groups F and G) induced 83.3% mortality. On the other hand
cysts from group H animals caused 50% of mortality in the naïve
recipients.
3.4. Cytokine measurement
Synthesis of IFN-c and IL-10 by splenocytes of BALB/c and
C57BL/6 mice was evaluated 45 days after prime-infection withFig. 2. Levels of IFN-c (A) and IL-10 (B) in BALB/c and C57BL/6 mice orally infected
with 20 cysts of the D8 Toxoplasma gondii strain (D8) and non infected (NI). IFN-c
and IL-10 were measured in the supernatant of splenocytes cultured with STAg.
Results obtained in the supernatant of splenocytes cultured with Con A or RPMI
medium alone are not shown. The values shown are the means of eight animals. The
experiment was repeated twice and provided similar results. Signiﬁcant differences
in the production of IFN-c or IL-10 in BALB/c (a) and C57BL/6 (b) mice are shown
with lower case letters.
Table 2
Pathological ﬁndings in the brain of mice infected with D8 and challenged with EGS or CH3 strains of Toxoplasma gondii.
Strains of T. gondii BALB/c C57BL/6
Group GNa PVIb Group GNa PVIb
D8 + EGS A 1.37 ± 1.50c 1.12 ± 1.12 F 2.16 ± 0.4 2.16 ± 2.2
D8 + CH3 B 1.42 ± 1.61 1.14 ± 1.2d G 2.5 ± 2.34 2 ± 1.67
D8 C 0 ± 0 0.25 ± 0.70 H 1.5 ± 1.37e 1.83 ± 1.47e
a Mean number of glial nodules in a total area of 1.5  106 lm2.
b Mean number of perivascular inﬂammatory inﬁltrates in a total area of 1.5  106 lm2.
c Signiﬁcant increase (p < 0.05) of glial nodules in relation to the non-challenged control – group C.
d Signiﬁcant increase (p < 0.05) of perivascular inﬂammatory inﬁltrates in relation to the non-challenged control – group C.
e Signiﬁcant increase (p < 0.05) of perivascular inﬂammatory inﬁltrates and glial nodules in relation to non-challenged BALB/c mice – group C.
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crease in the production of IFN-c and IL-10 after stimulation with
STAg, compared with the non-infected animals submitted to the
same stimulus (Fig. 2A and B). In C57BL/6 mice, there was a signif-
icant increase in the production of IFN-c after stimulus with STAg,
compared to non-infected animals submitted to the same stimulus
(Fig. 2A). Production of IL-10 in C57BL/6 mice did not reach signif-
icant levels compared to BALB/c mice (Fig. 2B).
3.5. Histopathology
Infection with D8 strain of T. gondii induced signiﬁcant pathol-
ogy in the brain of C57BL/6 mice but not in the brain of BALB/c
mice (group C). BALB/c mice challenged with EGS strain (group
A) presented a signiﬁcant increase in the number of glial nodules
compared to the animals infected only with D8 strain (Table 2).
BALB/c mice challenged with CH3 strain (group B) presented an in-
crease in the number of perivascular inﬂammatory inﬁltrates. No
signiﬁcant difference was observed in the number of perivascular
inﬁltrates and glial nodules in C57BL/6 mice challenged with the
strains EGS (group F) and CH3 (group G), compared to the animals
infected only with D8 strain (group H).4. Discussion
When BALB/c mice were prime infected with the non-virulent
D8 strain of T. gondii and challenged after 45 days with the virulent
EGS or CH3 strains, the mortality rate signiﬁcantly decreased, com-
pared to the mortality of mice infected only with the strains used
in the challenge. This probably occurred as a consequence of the
adaptive immune response conferred by the D8 strain. Such results
are similar to that previously described (Dzitko et al., 2006). Mice
challenged with a lethal dose of a virulent strain after a prime-
infection were found to survive due to the development of a strong
adaptive immune response capable of preventing the death of the
host. Re-infection with CH3 strain cannot be ruled out as cause of
death of two BALB/c mice. The PCR–RFLP of tissues of these ani-
mals could clarify this situation but unfortunately it was not pos-
sible to obtain their organs for analysis.
The C57BL/6 mice prime-infected with D8 strain and challenged
with EGS or CH3 strains also had a lower mortality rate than that
seen in prime-infected control animals. PCR–RFLP conﬁrmed the
co-existence of D8 and EGS strains in the brain of ﬁve (71%) surviv-
ing BALB/c mice challenged. DNA analysis showed that 100% of the
surviving C57BL/6 mice were re-infected with EGS and CH3 strains.
The presence of two clonal lines of T. gondii in the brain of mice
after experimental re-infection had been previously demonstrated
(Dao et al., 2001). These authors observed that primary infection
with the Prubgal T. gondii strain did not impair tissue cyst forma-
tion upon re-infection with the Ned strain of T. gondii, which be-
longs to another T. gondii clonal genotype. Bioassay mortalityrates conﬁrmed greater susceptibility of C57BL/6 to re-infection
with recombinant strains of T. gondii compared to BALB/c mice.
However RFLP–PCR has greater sensitivity than bioassay to detect
low brain cysts load of the strain used in the challenge.
Splenocytes of C57BL/6 mice produced signiﬁcant smaller
amounts of IFN-c than those of BALB/c mice and IL-10 was not
observed at signiﬁcant levels in C57BL/6 mice. The lower amount
of IFN-c and IL-10 in C57BL/6 mice probably favored re-infection
and the greater mortality rate observed in these animals com-
pared to BALB/c mice. IFN-c is crucial as mediator of adaptive
immunity (Pfaff et al., 2007), while IL-10 acts on the regulation
of the pro-inﬂammatory response (Lang et al., 2007). Also, IFN-
c and IL-10 produced by T cells are crucial for the elimination
of pathogens with minimum pathology or development of per-
sistent infection (O’Garra and Vieira, 2007). However the produc-
tion of IFN-c and IL-10 by splenocytes may not reﬂect the
presence of these cytokines in the brain, where pathology is
observed.
The inﬂammation in the brain of C57BL/6 mice infected only
with the D8 strain was more pronounced than in BALB/c mice.
Inﬂammation observed in BALB/c mice challenged with CH3 strain
probably occurred as a result of re-infection undetectable by PCR–
RFLP due to the low amount of CH3 strain DNA compared to D8
strain DNA. The inﬂammation observed in C57BL/6 mice does not
correspond to the smaller amount of IFN-c produced by these ani-
mals, compared with BALB/c mice. This suggested that pathology
in the brain of C57BL/6 mice can be attributed to a higher parasite
burden, associated with inability of this mouse line to control par-
asite replication via pro-inﬂammatory response. Other factors
associated with increased susceptibility of C57BL/6 mice to re-
infection still remain to be studied. It was recently observed that
increases IL-17 expression contributes to the inﬂammatory re-
sponse and susceptibility in C57BL/6 mice after T. gondii infection
(Guiton et al., 2010). Further studies are required in order to inves-
tigate cytokines levels in the brain and their involvement in the
pathology after re-infection by T. gondii.
Previously, we have shown that the genotype of the T. gondii
strain used in the challenge as well as the time between prime-
infection and challenge inﬂuence the re-infection rate (Brandão
et al., 2009). In this work, the occurrence of experimental re-infec-
tion by T. gondii varied as a function of the parasite strain and
mouse line. These observations lead to the conclusion that the
occurrence of re-infection is related not only to the genotype of
the parasite but also to the immune response of the host, which
is dependent on the mouse line used.Acknowledgments
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